Title: Antiplatelet treatment in primary and secondary stroke prevention in women.
Journal: European journal of internal medicine 20121001
Title: Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting.
Journal: Brain and behavior 20120301
Title: Effects of terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, on retinal vascularity in diabetic rats.
Journal: Diabetes/metabolism research and reviews 20120201
Title: Asymptomatic and symptomatic carotid stenosis: an obsolete classification?
Journal: Stroke research and treatment 20120101
Title: Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy.
Journal: Cardiology research and practice 20120101
Title: Aging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disorders.
Journal: Journal of aging research 20120101
Title: Thromboxane receptors antagonists and/or synthase inhibitors.
Journal: Handbook of experimental pharmacology 20120101
Title: Antiplatelet therapy: terutroban does not out-PERFORM aspirin in secondary prevention.
Journal: Nature reviews. Cardiology 20110621
Title: Vascular events after stroke: terutroban fails to PERFORM.
Journal: Lancet (London, England) 20110611
Title: Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
Journal: Lancet (London, England) 20110611
Title: Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis.
Journal: British journal of clinical pharmacology 20110601
Title: Design, data management, and population baseline characteristics of the PERFORM magnetic resonance imaging project.
Journal: Journal of neurology 20110501
Title: New therapeutic approaches to combat arterial thrombosis: better drugs for old targets, novel targets, and future prospects.
Journal: Molecular interventions 20110401
Title: Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis.
Journal: American journal of physiology. Heart and circulatory physiology 20110301
Title: Placebo - More hatred than love.
Journal: Journal of neurosciences in rural practice 20110101
Title: Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective.
Journal: International journal of endocrinology 20110101
Title: Dexmedetomidine induces both relaxations and contractions, via different {alpha}2-adrenoceptor subtypes, in the isolated mesenteric artery and aorta of the rat.
Journal: The Journal of pharmacology and experimental therapeutics 20101201
Title: Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study.
Journal: Journal of thrombosis and haemostasis : JTH 20101101
Title: Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.
Journal: Journal of cellular and molecular medicine 20101001
Title: Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.
Journal: The Journal of pharmacology and experimental therapeutics 20100701
Title: Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.
Journal: Drugs 20100507
Title: Rationale, design and population baseline characteristics of the PERFORM vascular project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial.
Journal: Cardiovascular drugs and therapy 20100401
Title: Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.
Journal: British journal of pharmacology 20100201
Title: [Update on new antithrombotic treatments].
Journal: Revue medicale suisse 20100120
Title: Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor.
Journal: Vascular health and risk management 20100101
Title: Emerging antiplatelet agents, differential pharmacology, and clinical utility.
Journal: Journal of blood medicine 20100101
Title: New antiplatelet agents: why they are needed.
Journal: European journal of internal medicine 20091201
Title: New antiplatelet agents.
Journal: Current opinion in hematology 20090901
Title: New antiplatelet drugs: beyond aspirin and clopidogrel.
Journal: International journal of clinical practice 20090501
Title: Update on oral antiplatelet therapy: principles, problems and promises.
Journal: Future cardiology 20090501
Title: Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20090101
Title: The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20090101
Title: TP receptor antagonism: a new concept in atherothrombosis and stroke prevention.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20090101
Title: Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20090101
Title: Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20090101
Title: Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat.
Journal: British journal of pharmacology 20080901
Title: Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban).
Journal: Critical care medicine 20080901
Title: Selective COX-2 inhibitors: new insights into mechanisms of side effects?
Journal: Critical care medicine 20080901
Title: Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review.
Journal: Stroke 20080501
Title: Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20080430
Title: The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Journal: Cardiovascular research 20080401
Title: Two isoforms of cyclooxygenase contribute to augmented endothelium-dependent contractions in femoral arteries of 1-year-old rats.
Journal: Acta pharmacologica Sinica 20080201
Title: The selective TP receptor antagonist, S18886 (terutroban), attenuates renal damage in the double transgenic rat model of hypertension.
Journal: American journal of nephrology 20080101
Title: Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice.
Journal: American journal of physiology. Renal physiology 20080101
Title: Increased spontaneous tone in renal arteries of spontaneously hypertensive rats.
Journal: American journal of physiology. Heart and circulatory physiology 20070901
Title: A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Journal: Thrombosis and haemostasis 20070901
Title: Renal effects of S18886 (Terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes.
Journal: Diabetes 20070401
Title: Preclinical evaluation of S18886 in an experimental model of coronary arterial thrombosis.
Journal: Journal of cardiovascular pharmacology 20061101
Title: TP receptor as a therapeutic target in atherosclerosis and related cardiovascular diseases.
Journal: Recent patents on cardiovascular drug discovery 20061101
Title: [Terutroban and endothelial TP receptors in atherogenesis].
Journal: Medecine sciences : M/S 20060401
Title: Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20060301
Title: The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice.
Journal: Diabetes 20060101
Title: Experimental models of thrombosis and atherosclerosis.
Journal: Therapie 20060101
Title: The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.
Journal: Circulation 20051108
Title: S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits.
Journal: Atherosclerosis 20051101
Title: Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study.
Journal: European heart journal 20050801
Title: The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies.
Journal: Journal of thrombosis and haemostasis : JTH 20050701
Title: Antithrombotic properties of the thromboxane A2/prostaglandin H2 receptor antagonist S18886 on prevention of platelet-dependent cyclic flow reductions in dogs.
Journal: Journal of cardiovascular pharmacology 20050501
Title: Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.
Journal: Circulation 20050125
Title: Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin.
Journal: Journal of the American College of Cardiology 20030402
Title: S-18886 Servier.
Journal: Current opinion in investigational drugs (London, England : 2000) 20020901
Title: Role of prostacyclin in the cardiovascular response to thromboxane A2.
Journal: Science (New York, N.Y.) 20020419
Title: Synthesis and biological evaluation of new tetrahydronaphthalene derivatives as thromboxane receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters 19980602
Title: De La Cruz JP, et al. Effects of terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, on retinal vascularity in diabetic rats. Diabetes Metab Res Rev. 2012 Feb;28(2):132-138.
Title: Bots ML, et al. Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trial. Stroke. 2014 Aug;45(8):2348-2353.
Title: Lesault PF, et al. Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis. Br J Clin Pharmacol.2011 Jun;71(6):844-851.
